fund

The new estimate includes the $700 billion Troubled Asset Relief Program, as well as other Federal Reserve and government programs.

The U.S. Treasury announced on Wednesday that government financial rescue programs have begun to turn a profit, and estimates a total profit of about $24 billion based on current market conditions.

The company has an unapproved drug, Protectan, which has so far shown to be effective in treating radiation sickness up to 48 hours after the initial exposure.

Chief Executive Michael Fonstein said Monday, "There are no approved drugs in this area, and we definitely believe we have a very potent remedy. Obviously, our drug is highly relevant. However, it is unlicensed.

Shares of Cleveland BioLabs (NASDAQ:CBLI) jumped sharply for the second day in a row, and are now trading up over 20% from its closing price just this past Friday.

This is what's in the news for Tuesday, March 1st, 2011. the New York Post reports that Morgan Stanley (MS) is said to be looking to complete the spin-off of FrontPoint Partners as early as today, even as the fund is being hur

This is what's in the news for Monday, February 28th. the Financial Times reports that JP Morgan’s (JPM) Digital Growth Fund is in talks to acquire a 10% stake in Twitter for $450M… the Wall Street Journal reports that FujiF

BP (BP) is criticizing Gulf of Mexico compensation fund administrator Kenneth Feinberg as being too generous with the use of the $20B set aside for settlements because they "exceed the extent of likely future damages because they

The company has stated that it will use the net proceeds to repay existing mortgage debt and for working capital and other general corporate purposes, including to fund future acquisitions or investments, should there be any.

The offering will close subject to customary closing conditions.

Shares are down 2.42% to $54.12.

Ventas (VTR) today announced that it has entered into an agreement to sell 5,563,000 shares of its common stock to UBS Investment Bank, as sole underwriter, in an underwritten public offering at a price to public of $54.07.